Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10735) 10735
Newsletter (313) 313
Newspaper Article (179) 179
Magazine Article (90) 90
Book Chapter (19) 19
Dissertation (19) 19
Government Document (7) 7
Publication (3) 3
Conference Proceeding (2) 2
Streaming Video (2) 2
Web Resource (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8150) 8150
male (5515) 5515
science & technology (5513) 5513
life sciences & biomedicine (5399) 5399
female (4940) 4940
albuterol - administration & dosage (4116) 4116
albuterol - therapeutic use (3922) 3922
asthma - drug therapy (3604) 3604
biological and medical sciences (3391) 3391
adult (3356) 3356
medical sciences (3177) 3177
respiratory system (2901) 2901
middle aged (2756) 2756
albuterol - pharmacology (2646) 2646
albuterol (2609) 2609
administration, inhalation (2377) 2377
pharmacology. drug treatments (2195) 2195
asthma (2083) 2083
bronchodilator agents - administration & dosage (1990) 1990
albuterol - analogs & derivatives (1971) 1971
abridged index medicus (1811) 1811
bronchodilator agents - therapeutic use (1744) 1744
aged (1691) 1691
salmeterol xinafoate (1685) 1685
adolescent (1654) 1654
animals (1652) 1652
double-blind method (1639) 1639
child (1518) 1518
asthma - physiopathology (1371) 1371
pharmacology & pharmacy (1272) 1272
nebulizers and vaporizers (1223) 1223
general & internal medicine (1149) 1149
albuterol - adverse effects (1136) 1136
treatment outcome (1029) 1029
salbutamol (1011) 1011
drug therapy, combination (1009) 1009
aerosols (953) 953
dose-response relationship, drug (926) 926
adrenergic beta-agonists - therapeutic use (895) 895
adrenergic beta-agonists - pharmacology (857) 857
time factors (825) 825
child, preschool (802) 802
adrenergic beta-agonists - administration & dosage (788) 788
forced expiratory volume (778) 778
drug therapy (733) 733
forced expiratory volume - drug effects (717) 717
pneumology (677) 677
fluticasone (672) 672
pulmonary disease, chronic obstructive - drug therapy (658) 658
respiratory function tests (641) 641
allergy (636) 636
pediatrics (635) 635
critical care medicine (613) 613
bronchodilator agents - pharmacology (611) 611
cross-over studies (607) 607
drug combinations (576) 576
salmeterol (565) 565
chronic obstructive pulmonary disease, asthma (564) 564
analysis (563) 563
acute disease (552) 552
research (550) 550
medicine, general & internal (528) 528
infant (522) 522
rats (520) 520
formoterol fumarate (518) 518
albuterol - chemistry (492) 492
androstadienes - administration & dosage (488) 488
heart rate - drug effects (487) 487
bronchodilator agents - adverse effects (480) 480
clinical trials as topic (472) 472
immunology (464) 464
in vitro techniques (462) 462
isoproterenol - pharmacology (460) 460
antiasthmatic agents (453) 453
dosage and administration (438) 438
respiratory tract diseases (438) 438
androstadienes - therapeutic use (434) 434
spirometry (432) 432
prospective studies (422) 422
chemistry (417) 417
care and treatment (410) 410
physical sciences (406) 406
general pharmacology (402) 402
particle size (391) 391
research article (389) 389
administration, oral (387) 387
albuterol - pharmacokinetics (385) 385
drug administration schedule (385) 385
lung diseases, obstructive - drug therapy (372) 372
severity of illness index (369) 369
asthma - diagnosis (367) 367
peak expiratory flow rate (361) 361
health aspects (360) 360
guinea pigs (358) 358
fundamental and applied biological sciences. psychology (353) 353
adrenergic beta-agonists - adverse effects (350) 350
bronchi - drug effects (346) 346
anti-asthmatic agents - administration & dosage (345) 345
anti-asthmatic agents - therapeutic use (345) 345
ethanolamines - therapeutic use (345) 345
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10589) 10589
French (185) 185
German (158) 158
Italian (136) 136
Spanish (113) 113
Japanese (96) 96
Polish (83) 83
Chinese (55) 55
Russian (55) 55
Portuguese (51) 51
Danish (20) 20
Dutch (15) 15
Romanian (12) 12
Croatian (8) 8
Norwegian (8) 8
Swedish (4) 4
Czech (3) 3
Hebrew (3) 3
Hungarian (3) 3
Serbian (3) 3
Turkish (3) 3
Finnish (2) 2
Korean (2) 2
Persian (1) 1
Slovak (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Phosphodiesterases inhibition unmask a positive inotropic effect mediated by [beta].sub.2-adrenoceptors in rat ventricular myocardium
by Gonzalez-MuA[+ or -]oz, C and Fuente, Teodomiro and Hernandez-Cascales, J
European journal of pharmacology, ISSN 0014-2999, 04/2009, Volume 607, Issue 1-3, p. 151
Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Effect of graphite and metallic impurities of C.sub.60 fullerene on determination of salbutamol in biological fluids
by Goyal, Rajendra N and Kaur, Davinder and Singh, Sudhanshu P and Pandey, Ashish K
Talanta (Oxford), ISSN 0039-9140, 03/2008, Volume 75, Issue 1, p. 63
Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text 126 An Observational Study of Albuterol Administration by Basic Life Support Providers
by Morgan, S and Matthews, P and Papas, M.A and Davis, B and Megargel, R
Annals of emergency medicine, ISSN 0196-0644, 2016, Volume 68, Issue 4, pp. S50 - S50
Emergency | Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study
by Bateman, Eric D and Boushey, Homer A and Bousquet, Jean and Busse, William W and Clark, Tim J. H and Pauwels, Romain A and Pedersen, Soren E and GOAL Investigators Group and GOAL Investigators Grp and GOAL Investigators Group
American journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2004, Volume 170, Issue 8, pp. 836 - 844
Antiasthmatic agents | Salmeterol | Fluticasone propionate | Guidelines | Quality of life | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care | Biological and medical sciences | Intensive care medicine | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Bronchodilator Agents - therapeutic use | Prospective Studies | Asthma - prevention & control | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Anti-Asthmatic Agents - therapeutic use | Humans | Male | Fluticasone | Adrenal Cortex Hormones - therapeutic use | Dose-Response Relationship, Drug | Time Factors | Albuterol - administration & dosage | Adult | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Salmeterol Xinafoate | Double-Blind Method | Albuterol - analogs & derivatives | Treatment Outcome | Asthma - drug therapy | Androstadienes - administration & dosage | Quality of Life | Albuterol - therapeutic use | Androstadienes - therapeutic use | Anti-Asthmatic Agents - administration & dosage | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Practice Guidelines as Topic | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Adjuvant oral salbutamol in treatment of juvenile Pompe disease: novel outcome assessment tool and initial report one-year efficacy in single case
by Wood, Michelle and Gissen, Paul and Davison, James E
Molecular genetics and metabolism, ISSN 1096-7192, 01/2017, Volume 120, Issue 1-2, pp. S142 - S142
Reports | Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text 373 Prospective Exploratory Pilot Study of Hyperlactatemia After Albuterol Therapy
by Ramich, J.L and Timm, E.G and Robak, N and Ata, A and Cohen, J
Annals of emergency medicine, ISSN 0196-0644, 2015, Volume 66, Issue 4, pp. S136 - S136
Emergency | Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma
by Bateman, Eric D., MD and Kornmann, Oliver, MD and Schmidt, Peter, PhD and Pivovarova, Anna, DiplStat and Engel, Michael, MD and Fabbri, Leonardo M., MD
Journal of allergy and clinical immunology, ISSN 0091-6749, 2011, Volume 128, Issue 2, pp. 315 - 322
Allergy and Immunology | airway obstruction | agonist receptor | bronchodilators | Arginine/arginine genotype | muscarinic receptor | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Immunopathology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Male | Arginine - genetics | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Female | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Asthma - physiopathology | Double-Blind Method | Receptors, Adrenergic, beta-2 - genetics | Administration, Inhalation | Albuterol - analogs & derivatives | Genotype | Treatment Outcome | Asthma - drug therapy | Asthma - genetics | Polymorphism, Single Nucleotide - genetics | Albuterol - therapeutic use | Respiratory Function Tests | Peak Expiratory Flow Rate | Albuterol - adverse effects | Antiasthmatic agents | Corticosteroids | Asthma | Studies | Chronic obstructive pulmonary disease | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol
by Casarosa, Paola and Kollak, Ines and Kiechle, Tobias and Ostermann, Angela and Schnapp, Andreas and Kiesling, Ralf and Pieper, Michael and Sieger, Peter and Gantner, Florian
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 06/2011, Volume 337, Issue 3, pp. 600 - 609
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Adrenergic beta-2 Receptor Agonists - pharmacokinetics | Ethanolamines - pharmacology | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Albuterol - pharmacology | Humans | Half-Life | Pulmonary Disease, Chronic Obstructive - physiopathology | Ethanolamines - administration & dosage | Adrenergic beta-2 Receptor Agonists - pharmacology | Bronchodilator Agents - chemistry | Ethanolamines - pharmacokinetics | Benzoxazines - pharmacokinetics | Albuterol - administration & dosage | Binding Sites | Benzoxazines - chemistry | Cricetinae | Salmeterol Xinafoate | Benzoxazines - administration & dosage | Adrenergic beta-2 Receptor Agonists - chemistry | Administration, Inhalation | Albuterol - analogs & derivatives | Albuterol - pharmacokinetics | Bronchodilator Agents - pharmacology | Receptors, Adrenergic, beta-1 - metabolism | Ethanolamines - chemistry | Asthma - drug therapy | Receptors, Adrenergic, beta-2 - metabolism | Animals | Bronchodilator Agents - pharmacokinetics | Benzoxazines - pharmacology | Adrenergic beta-2 Receptor Agonists - administration & dosage | Albuterol - chemistry | Mice | Mice, Inbred BALB C | Lipid Bilayers - metabolism | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Details down arrow
9. Full Text The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor
by Warne, Tony and Moukhametzianov, Rouslan and Baker, Jillian G and Nehme, Rony and Edwards, Patricia C and Leslie, Andrew G. W and Schertler, Gebhard F. X and Tate, Christopher G
Nature (London), ISSN 0028-0836, 01/2011, Volume 469, Issue 7329, pp. 241 - 244
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Dobutamine - metabolism | Hydroxyquinolines - chemistry | Catecholamines - metabolism | Albuterol - pharmacology | Amphetamines - pharmacology | Adrenergic beta-1 Receptor Antagonists - pharmacology | Crystallography, X-Ray | Adrenergic beta-1 Receptor Agonists - chemistry | Structure-Activity Relationship | Receptors, Adrenergic, beta-1 - chemistry | Adrenergic beta-1 Receptor Agonists - pharmacology | Turkeys | Adrenergic beta-1 Receptor Antagonists - chemistry | Drug Design | Adrenergic beta-1 Receptor Antagonists - metabolism | Dobutamine - chemistry | Isoproterenol - chemistry | Binding Sites | Hydroxyquinolines - pharmacology | Amphetamines - chemistry | Drug Partial Agonism | Albuterol - metabolism | Hydroxyquinolines - metabolism | Isoproterenol - metabolism | Models, Molecular | Receptors, Adrenergic, beta-1 - metabolism | Serine - chemistry | Serine - metabolism | Dobutamine - pharmacology | Animals | Hydrogen Bonding | Amphetamines - metabolism | Isoproterenol - pharmacology | Protein Stability - drug effects | Albuterol - chemistry | Ligands | Protein Conformation | Adrenergic beta-1 Receptor Agonists - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Prevalence and progression of osteoporosis in patients with COPD: Results from the towards a revolution in COPD health study
by Ferguson, Gary T and Calverley, Peter M. A and Anderson, Julie A and Jenkins, Christine R and Jones, Paul W and Willits, Lisa R and Yates, Julie C and Vestbo, Jørgen and Celli, Bartolome
Chest, ISSN 0012-3692, 12/2009, Volume 136, Issue 6, pp. 1456 - 1465
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Osteoporosis. Osteomalacia. Paget disease | Diseases of the osteoarticular system | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Bone Diseases, Metabolic - epidemiology | Prevalence | Prospective Studies | Albuterol - pharmacology | United States | Humans | Middle Aged | Fractures, Bone - epidemiology | Male | Fluticasone | Bone Diseases, Metabolic - complications | Female | Bronchodilator Agents - adverse effects | Osteoporosis - epidemiology | Salmeterol Xinafoate | Osteoporosis - chemically induced | Double-Blind Method | Risk Factors | Albuterol - analogs & derivatives | Bronchodilator Agents - pharmacology | Treatment Outcome | Pulmonary Disease, Chronic Obstructive - complications | Bone Diseases, Metabolic - chemically induced | Disease Progression | Bone Density - drug effects | Androstadienes - pharmacology | Osteoporosis - complications | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Fluticasone-Salmeterol Drug Combination | Androstadienes - adverse effects | Albuterol - adverse effects | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Osteoporosis | Complications and side effects | Development and progression | Lung diseases, Obstructive | Corticosteroids | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease
by Kardos, Peter and Wencker, Marion and Glaab, Thomas and Vogelmeier, Claus
American journal of respiratory and critical care medicine, ISSN 1073-449X, 01/2007, Volume 175, Issue 2, pp. 144 - 149
Exacerbation | Combination treatment | Chronic obstructive pulmonary disease | Inhaled corticosteroids | agonists | Long-acting β | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Salmeterol Xinafoate | Bronchodilator Agents - administration & dosage | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Albuterol - analogs & derivatives | Male | Fluticasone | Androstadienes - administration & dosage | Lung - drug effects | Albuterol - administration & dosage | Quality of Life | Albuterol - therapeutic use | Female | Aged | Androstadienes - therapeutic use | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Androstadienes - adverse effects | Albuterol - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Reported pneumonia in patients with COPD: Findings from the INSPIRE study
by Calverley, Peter M. A and Stockley, Robert A and Seemungal, Terence A. R and Hagan, Gerry and Willits, Lisa R and Riley, John H and Wedzicha, Jadwiga A and INSPIRE Investigators and Investigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) Investigators
Chest, ISSN 0012-3692, 03/2011, Volume 139, Issue 3, pp. 505 - 512
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Fluticasone | Adrenal Cortex Hormones - therapeutic use | C-Reactive Protein - metabolism | Pneumonia - mortality | Pneumonia - chemically induced | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Female | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Double-Blind Method | Pneumonia - epidemiology | Risk Factors | Kaplan-Meier Estimate | Administration, Inhalation | Albuterol - analogs & derivatives | Pulmonary Disease, Chronic Obstructive - complications | Adrenal Cortex Hormones - adverse effects | Androstadienes - administration & dosage | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Usage | Pneumonia | Corticosteroids | Bacterial pneumonia | Research | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Sulfate radical induced degradation of [beta]2-adrenoceptor agonists salbutamol and terbutaline: Phenoxyl radical dependent mechanisms
by Zhou, Lei and Sleiman, Mohamad and Ferronato, Corinne and Chovelon, Jean-Marc and de Sainte-Claire, Pascal and Richard, Claire
Water research (Oxford), ISSN 0043-1354, 10/2017, Volume 123, p. 715
Photolysis | Quinone | Albuterol | Sulfates
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Analysis of 10 [beta]-agonists in pork meat using automated dispersive pipette extraction and LC-MS/MS
by Mastrianni, Kaylee R and Metavarayuth, Kalmorat and Brewer, William E and Wang, Qian
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, ISSN 1570-0232, 05/2018, Volume 1084, p. 64
Analysis | Albuterol | Pork
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
by Vogelmeier, Claus and Hederer, Bettina and Glaab, Thomas and Schmidt, Hendrik and Rutten-van Mölken, Maureen P.M.H and Beeh, Kai M and Rabe, Klaus F and Fabbri, Leonardo M and POET-COPD Investigators
The New England journal of medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 12, pp. 1093 - 1103
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Prevention and actions | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Glucocorticoids - therapeutic use | Humans | Middle Aged | Male | Adrenergic beta-2 Receptor Agonists - adverse effects | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Cholinergic Antagonists - adverse effects | Scopolamine Derivatives - therapeutic use | Cholinergic Antagonists - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Double-Blind Method | Pneumonia - epidemiology | Kaplan-Meier Estimate | Proportional Hazards Models | Administration, Inhalation | Albuterol - analogs & derivatives | Pulmonary Disease, Chronic Obstructive - prevention & control | Albuterol - therapeutic use | Aged | Albuterol - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Prevention | Tiotropium | Lung diseases, Obstructive | Salmeterol | Causes of | Comparative analysis | Drug therapy | Chronic obstructive pulmonary disease | Statistical analysis | Pharmaceutical industry | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Voltammetric behavior of complexation of salbutamol with calf thymus DNA and its analytical application
by Wang, Yingxia and Ni, Yongnian and Kokot, Serge
Analytical biochemistry, ISSN 0003-2697, 2011, Volume 419, Issue 2, pp. 76 - 80
Fluorescence spectroscopy | Voltammetry | Salbutamol | MCR–ALS | DNA | MCR-ALS | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Multivariate Analysis | Oxidation-Reduction | Humans | Spectrometry, Fluorescence | Glass - chemistry | Carbon - chemistry | Albuterol - analysis | Electrodes | DNA - chemistry | Animals | Cattle | Least-Squares Analysis | Albuterol - chemistry | Albuterol - urine | Electrochemical Techniques - methods | Albuterol - blood | Hydrogen-Ion Concentration | Genetic research | Fluorescence | Antiasthmatic agents | Albuterol | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights